Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

13小时前 ms7000001882498165 来自海南省

偏重的研究方向：生物信息学;肿瘤
经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

21小时前 ms2000000610251641 来自广东省

记录过程 24-5-9投稿并技术审查

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-04-18 ms7000000828059346 来自贵州省

想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答

11 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-05-02 峪奇不奇来自四川省

投稿命中率:25.0
偏重的研究方向：肿瘤;生信
经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？
The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process.

8 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-04-18 ms6000000096574231 来自海南省

Peer review
Submission status Date
Submission accepted
16 Apr 2024
Submission under peer review
25 Mar 2024
Submission passed technical check
25 Mar 2024
Revision received
22 Mar 2024
Submission under peer review
06 Mar 2024
Submission passed technical check
06 Mar 2024
Amendment received
05 Mar 2024
Revision received
02 Mar 2024
Submission under peer review
24 Dec 2023
Submission passed technical check
24 Dec 2023
Amendment received
24 Dec 2023
Revision received
21 Dec 2023
Submission under peer review
07 Sep 2023
Technical check
Submission status Date
Submission passed technical check
07 Sep 2023
Amendment received
28 Aug 2023
Submission is under technical check
26 Aug 2023
Submission received
Submission status Date
Submission received
26 Aug 2023
初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。

15 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-04-24 ms3000002137239896 来自广东省

偏重的研究方向：生物信息学
经验分享：想问问各位前辈，peer review是with editor还是已经under review

15 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-04-26 ms3000000356363946 来自江苏省

这篇审稿周期是多少

11 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-02-25 尽在不言中来自吉林省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗

26 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-04-20 ms2000000667012500 来自江苏省

有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?

37 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203816, encodeId=e0712203816c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：peer review四个多月，通过联系编辑部那个按钮前后发送了三篇退稿信，半个多月了，还是没有回复，还有其他撤稿途径吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=863e9047804, createdName=ms7000001882498165, createdTime=Fri May 10 07:00:27 CST 2024, time=13小时前, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2203757, encodeId=04282203e57ea, content=记录过程 24-5-9投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a06573271, createdName=ms2000000610251641, createdTime=Thu May 09 22:10:57 CST 2024, time=21小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=想问一下大家投稿状态显示peer view这个状态大概会持续多久？我这边已经快持续20天了，我看其他人有些会显示审稿人邀请和几个审稿人，我这个怎么没显示，还是说现在已经统一都只显示peer view啊？谢谢大家解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=2024-04-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2201443, encodeId=d6712201443d8, content=投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：1月中旬投的，一直peer review，催了一次，编辑这样回复我的，怎么办？要不要撤稿？ The Editorial Board Member who is handling your submission initially had some difficulty securing referees who were available to review your manuscript, but I am pleased to say that your manuscript is now out for review, and we are currently waiting for the last report to be returned. We are continuing to do our utmost to ensure that it is returned to us in a timely fashion. I am terribly sorry for this delay, and we greatly appreciate your continued patience with this process. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Thu May 02 10:33:46 CST 2024, time=2024-05-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2199122, encodeId=57bb219912235, content=Peer review Submission status Date Submission accepted 16 Apr 2024 Submission under peer review 25 Mar 2024 Submission passed technical check 25 Mar 2024 Revision received 22 Mar 2024 Submission under peer review 06 Mar 2024 Submission passed technical check 06 Mar 2024 Amendment received 05 Mar 2024 Revision received 02 Mar 2024 Submission under peer review 24 Dec 2023 Submission passed technical check 24 Dec 2023 Amendment received 24 Dec 2023 Revision received 21 Dec 2023 Submission under peer review 07 Sep 2023 Technical check Submission status Date Submission passed technical check 07 Sep 2023 Amendment received 28 Aug 2023 Submission is under technical check 26 Aug 2023 Submission received Submission status Date Submission received 26 Aug 2023 初审有审稿人跑路，编辑又邀请了一个审稿人，多审了一轮，总共四个审稿人。提的问题很专业，应该都是同领域的同行。针对一个审稿人得问题来回拉扯了一下，看得出编辑很犹豫，最后写邮件据理力争了一下我们理由，最后赢得了审稿人的认可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aec75705648, createdName=ms6000000096574231, createdTime=Thu Apr 18 14:34:16 CST 2024, time=2024-04-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2200052, encodeId=b4ed220005285, content=偏重的研究方向：生物信息学 经验分享：想问问各位前辈，peer review是with editor还是已经under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea19160448, createdName=ms3000002137239896, createdTime=Wed Apr 24 00:39:43 CST 2024, time=2024-04-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200514, encodeId=0ae922005141e, content=这篇审稿周期是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90348714293, createdName=ms3000000356363946, createdTime=Fri Apr 26 13:13:44 CST 2024, time=2024-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2199468, encodeId=87ea2199468ca, content=有最近投稿的吗?一个半月了还在邀请编辑，有和我一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=025c5502748, createdName=ms2000000667012500, createdTime=Sat Apr 20 18:17:43 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管 经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=2024-04-17, status=1, ipAttribution=湖北省)]

2024-04-17 ms4000001914246765 来自湖北省

偏重的研究方向：心血管
经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查

18 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务